FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Henry Pitot

Research Profile

Living Beings

Disorders

Anatomy

Livers

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sean F Jabbar; Marthe Berard-Bergery; Denis Lee; Soyeong Park; Henry C Pitot; Johannes Schweizer; Paul F Lambert
Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein.
Julie R Brahmer; Luis H Camacho; Shuming Chen; Laura Q M Chow; Charles G Drake; Keith Eaton; Stacie M Goldberg; Joseph F Grosso; Ashok Gupta; Omid Hamid; Patrick Hwu; Wen-Jen Hwu; John Kauh; Alan J Korman; Renato Martins; Kunle Odunsi; Drew M Pardoll; Susan M Parker; Henry C Pitot; Theresa M Salay; Suzanne Topalian; Scott S Tykodi; Shruti Agrawal; Suresh Alaparthy; Shailender Bhatia; JON WIGGINTON
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Philip A Philip; Joel Picus; Henry C Pitot; Patrick J Flynn; Kyle D Holen; Michelle R Mahoney; Donald W Northfelt; Charles Erlichman
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Henry Pitot (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sean F Jabbar; Marthe Berard-Bergery; Denis Lee; Soyeong Park; Henry C Pitot; Johannes Schweizer; Paul F Lambert
Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein.
Cancer research 2012;72(16):4008-16.
2012: Julie R Brahmer; Luis H Camacho; Shuming Chen; Laura Q M Chow; Charles G Drake; Keith Eaton; Stacie M Goldberg; Joseph F Grosso; Ashok Gupta; Omid Hamid; Patrick Hwu; Wen-Jen Hwu; John Kauh; Alan J Korman; Renato Martins; Kunle Odunsi; Drew M Pardoll; Susan M Parker; Henry C Pitot; Theresa M Salay; Suzanne Topalian; Scott S Tykodi; Shruti Agrawal; Suresh Alaparthy; Shailender Bhatia; JON WIGGINTON
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
The New England journal of medicine 2012;366(26):2455-65.
2012: Philip A Philip; Joel Picus; Henry C Pitot; Patrick J Flynn; Kyle D Holen; Michelle R Mahoney; Donald W Northfelt; Charles Erlichman
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.
Cancer 2012;118(9):2424-30.
2012: Myeong-Kyun Shin; Henry C Pitot; Paul F Lambert
Pocket proteins suppress head and neck cancer.
Cancer research 2012;72(5):1280-9.
2012: Jan Franko; Richard M Goldberg; Charles D Goldman; Axel Grothey; Garth D Nelson; Henry C Pitot; Barbara A Pockaj; Steven R Alberts; Qian Shi; Daniel J Sargent
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(3):263-7.
2011: Marie K Thomas; Amy Liem; Henry C Pitot; Paul F Lambert
Dominant role of HPV16 E7 in anal carcinogenesis.
Virology 2011;421(2):114-8.
2011: Ming-Wen An; Megan E Branda; Richard M Goldberg; Shauna L Hillman; Sumithra J Mandrekar; Henry C Pitot; Alex A. Adjei; Daniel J Sargent
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(20):6592-9.
2011: Kimmie Ng; Daniel J Sargent; Richard M Goldberg; Jeffrey A Meyerhardt; Erin M Green; Henry C Pitot; Bruce W Hollis; Michael N Pollak; Charles S Fuchs
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1599-606.
2010: Marie K Stelzer; Henry C Pitot; Amy Liem; Denis Lee; Gregory D Kennedy; Paul F Lambert
Rapamycin inhibits anal carcinogenesis in two preclinical animal models.
Cancer prevention research (Philadelphia, Pa.) 2010;3(12):1542-51.
2010: Marie K Stelzer; Henry C Pitot; Amy Liem; Johannes Schweizer; Charles Mahoney; Paul F Lambert
A mouse model for human anal cancer.
Cancer prevention research (Philadelphia, Pa.) 2010;3(12):1534-41.
2010: Jung Wook Park; Henry C Pitot; Katerina Strati; Nicole Spardy; Stefan Duensing; Markus Grompe; Paul F Lambert
Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Cancer research 2010;70(23):9959-68.
2010: Sean Jabbar; Katerina Strati; Myeong-Kyun Shin; Henry C Pitot; Paul F Lambert
Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice.
Virology 2010;407(1):60-7.
2010: Nicholas M Orme; Joel G Fletcher; Hassan A Siddiki; W Scott Harmsen; Megan M O'Byrne; John D Port; William J Tremaine; Henry C Pitot; Elizabeth G McFarland; Marguerite E Robinson; Barbara A Koenig; Bernard F King; Susan M Wolf
Incidental findings in imaging research: evaluating incidence, benefit, and burden.
Archives of internal medicine 2010;170(17):1525-32.
2010: Sam J Lubner; Michelle R Mahoney; Jill L Kolesar; Noelle K Loconte; George P Kim; Henry C Pitot; Philip A Philip; Joel Picus; Wei-Peng Yong; Lisa Horvath; Guy Van Hazel; Charles E Erlichman; Kyle D Holen
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(21):3491-7.
2010: Anny Shai; Henry C Pitot; Paul F Lambert
E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.
Cancer research 2010;70(12):5064-73.
2010: John P Maufort; Anny Shai; Henry C Pitot; Paul F Lambert
A role for HPV16 E5 in cervical carcinogenesis.
Cancer research 2010;70(7):2924-31.
2009: Alicia G Cleveland; Seija I Oikarinen; Kimberly K Bynoté; Maija Marttinen; Joseph Rafter; Jan-Ake Gustafsson; Shyamal K Roy; Henry C Pitot; Kenneth S Korach; Dennis B Lubahn; Marja Mutanen; Karen A Gould
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice.
Carcinogenesis 2009;30(9):1581-90.
2009: Richard B Halberg; Jesse Waggoner; Kristen Rasmussen; Alanna White; Linda Clipson; Amy J Prunuske; Jeff Bacher; Ruth Sullivan; Mary Kay Washington; Henry C Pitot; John H J Petrini; Donna G Albertson; William F Dove
Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway.
Cancer research 2009;69(14):5768-75.
2009: George P Kim; Daniel J Sargent; Michelle R Mahoney; Kendrith M Rowland; Philip A Philip; Edith Mitchell; Abraham P Mathews; Tom R Fitch; Richard M Goldberg; Steven R Alberts; Henry C Pitot
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2848-54.
2009: Stephanie E-M Peychal; Andrea Bilger; Henry C Pitot; Norman R Drinkwater
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.
Carcinogenesis 2009;30(5):879-85.
2008: Hanna Sanoff; Daniel J Sargent; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5721-7.
2008: Elisabeth Iljas Heath; David W Hillman; Ulka Nitin Vaishampayan; Shijie Sheng; Asfar S Azmi; Felicity WK Harper; Melvin Gaskins; Henry C Pitot; Winston Tan; S Percy Ivy; Roberto Pili; Michael A Carducci; Charles Erlichman; Glenn Liu
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7940-6.
2008: Richard B Halberg; Xiaodi Chen; James M Amos-Landgraf; Alanna White; Kristin Rasmussen; Linda Clipson; Cheri Pasch; Ruth Sullivan; Henry C Pitot; William F Dove
The pleiotropic phenotype of Apc mutations in the mouse: allele specificity and effects of the genetic background.
Genetics 2008;180(1):601-9.
2008: Steven Attia; Jill M Kolesar; Michelle R Mahoney; Henry C Pitot; Daniel Laheru; James Heun; Wei Huang; Jens Eickhoff; Charles Erlichman; Kyle D Holen
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.
Investigational new drugs 2008;26(4):369-79.
2008: Anny Shai; Henry C Pitot; Paul F Lambert
p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
Cancer research 2008;68(8):2622-31.
2007: Yi-Hua Xu; Herbert T Manoharan; Henry C Pitot
CpG PatternFinder: a Windows-based utility program for easy and rapid identification of the CpG methylation status of DNA.
BioTechniques 2007;43(3):334, 336-40, 342.
2007: Matthew J Czarny; Karlee Babcock; Rebecca M Baus; Herbert Manoharan; Henry C Pitot
Hepatocellular carcinomas of the albumin SV40 T-antigen transgenic rat display fetal-like re-expression of lgf2 and deregulation of H19.
Molecular carcinogenesis 2007;46(9):747-57.
2007: Grace K Dy; James E Krook; Erin M Green; Daniel J Sargent; Thierry Delaunoit; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Barbara A Pockaj; Robert P Sticca; Steven R Alberts; Henry C Pitot; Richard M Goldberg
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3469-74.
2007: Amanda C Ashley; Daniel J Sargent; Steven R Alberts; Axel Grothey; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Cancer 2007;110(3):670-7.
2007: John P Maufort; Sybil M Genther Williams; Henry C Pitot; Paul F Lambert
Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis.
Cancer research 2007;67(13):6106-12.
2007: Svetomir N Markovic; Vera J Suman; Ravi A Rao; James N Ingle; Judith S Kaur; Lori A Erickson; Henry C Pitot; Gary A Croghan; Robert R McWilliams; Jaime Merchan; Lisa A Kottschade; Wendy K Nevala; Cindy B Uhl; Jacob Allred; Edward T. Creagan
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.
American journal of clinical oncology 2007;30(3):303-9.
2007: Cynthia Ma; Sumithra J Mandrekar; Steven R Alberts; Gary A Croghan; Aminah Jatoi; Joel M Reid; Lorelei J Hanson; Laura M Bruzek; Angelina D Tan; Henry C Pitot; Charles Erlichman; John J Wright; Alex A. Adjei
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies.
Cancer chemotherapy and pharmacology 2007;59(2):207-15.
2007: Steven R Alberts; Vera J Suman; Henry C Pitot; John K Camoriano; Joseph Rubin
Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
Journal of gastrointestinal cancer 2007;38(1):10-4.
2007: Henry C Pitot
Adventures in hepatocarcinogenesis.
Annual review of pathology 2007;2():1-29.
2006: Katerina Strati; Henry C Pitot; Paul F Lambert
Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(38):14152-7.
2006: Svetomir N Markovic; Vera J Suman; James N Ingle; Judith S Kaur; Henry C Pitot; Charles L Loprinzi; Ravi D Rao; Edward T. Creagan; Mark Pittelkow; Jakob B Allred; Wendy K Nevala; Esteban Celis
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.
American journal of clinical oncology 2006;29(4):352-60.
2006: Henry C Pitot; Alex A. Adjei; Joel M Reid; Jeff A Sloan; Pamela J Atherton; Joseph Rubin; Steven R Alberts; Barbara A Duncan; Louis Denis; Larry J Schaaf; Donghua Yin; Amarnath Sharma; Patrick McGovren; Langdon L Miller; Charles Erlichman
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2006;58(2):165-72.
2006: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven Alberts
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3347-53.
2006: Philip A Philip; Michelle R Mahoney; Cristine Allmer; James P Thomas; Henry C Pitot; George Kim; Ross C Donehower; Tom R Fitch; Joel Picus; Charles Erlichman
Phase II study of erlotinib in patients with advanced biliary cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3069-74.
2006: Hirofumi Ogawa; Tomoharu Gomi; Mikio Nishizawa; Yumiko Hayakawa; Shunro Endo; Kyoko Hayashi; Hiroshi Ochiai; Fusao Takusagawa; Henry C Pitot; Hisashi Mori; Hiroaki Sakurai; Keiichi Koizumi; Ikuo Saiki; Hirofumi Oda; Takashi Fujishita; Toshiro Miwa; Muneharu Maruyama; Masashi Kobayashi
Enzymatic and biochemical properties of a novel human serine dehydratase isoform.
Biochimica et biophysica acta 2006;1764(5):961-71.
2006: Yihua Xu; Henry C Pitot
A software package to improve image quality and isolation of objects of interest for quantitative stereology studies of rat hepatocarcinogenesis.
Computer methods and programs in biomedicine 2006;81(3):236-45.
2006: Ravi D Rao; Shernan G Holtan; James N Ingle; Gary A Croghan; Lisa A Kottschade; Edward T. Creagan; Judith S Kaur; Henry C Pitot; Svetomir N Markovic
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.
Cancer 2006;106(2):375-82.
2005: Yi-Hua Xu; Herbert T Manoharan; Henry C Pitot
CpG analyzer, a Windows-based utility program for investigation of DNA methylation.
BioTechniques 2005;39(5):656, 658, 660 passim.
2005: Philip A Philip; Michelle R Mahoney; Cristine Allmer; James P Thomas; Henry C Pitot; George Kim; Ross C Donehower; Tom R Fitch; Joel Picus; Charles Erlichman
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6657-63.
2005: Elisabeth Iljas Heath; Melvin Gaskins; Henry C Pitot; Roberto Pili; Winston Tan; Robert Marschke; Glenn Liu; David Hillman; Asfar S Azmi; Shijie Sheng; Charles Erlichman; Percy Ivy
A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
Clinical prostate cancer 2005;4(2):138-41.
2005: Grace K Dy; Ajit Suri; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Pamela J Atherton; Lorelei J Hanson; Patrick A Burch; Joseph Rubin; Charles Erlichman; Alex A. Adjei
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2005;55(6):522-30.
2005: Grace K Dy; James P Thomas; George Wilding; Laura M Bruzek; Sumithra J Mandrekar; Charles Erlichman; Dona Alberti; Kim Binger; Henry C Pitot; Steven R Alberts; Lorelei J Hanson; Rebecca Marnocha; Kendra Tutsch; Scott H Kaufmann; Alex A. Adjei
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3410-6.
2005: Grace K Dy; Laura M Bruzek; Gary A Croghan; Sumithra J Mandrekar; Charles Erlichman; Prema P Peethambaram; Henry C Pitot; Lorelei J Hanson; Joel M Reid; Alfred F Furth; Shinta Cheng; Robert E Martell; Scott H Kaufmann; Alex A. Adjei
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(5):1877-83.
2005: Tatsuhiko Kashii; Tomoharu Gomi; Takeshi Oya; Yoko Ishii; Hirofumi Oda; Muneharu Maruyama; Masashi Kobayashi; Tohru Masuda; Mitsuaki Yamazaki; Takuya Nagata; Kazuhiro Tsukada; Akinori Nakajima; Kazuhito Tatsu; Hisashi Mori; Fusao Takusagawa; Hirofumi Ogawa; Henry C Pitot
Some biochemical and histochemical properties of human liver serine dehydratase.
The international journal of biochemistry & cell biology 2005;37(3):574-89.
2005: Garet P Lahvis; Robert W Pyzalski; Edward Glover; Henry C Pitot; Matthew K McElwee; Christopher A Bradfield
The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse.
Molecular pharmacology 2005;67(3):714-20.
2004: Evanthia C Galanis; Patrick A Burch; Ronald L Richardson; Bradley Lewis; Henry C Pitot; Stephen Frytak; Catherine Spier; Emmanuel T Akporiaye; Prema P Peethambaram; Judith S Kaur; Scott H Okuno; K Krishnan Unni; Joseph Rubin
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
Cancer 2004;101(11):2557-66.
2004: Yi-Hua Xu; Garet P Lahvis; Harlene Edwards; Henry C Pitot
Three-dimensional reconstruction from serial sections in PC-Windows platform by using 3D_Viewer.
Computer methods and programs in biomedicine 2004;76(2):143-54.
2004: Herbert Manoharan; Karlee Babcock; Henry C Pitot
Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
Molecular carcinogenesis 2004;41(1):1-16.
2004: Yvonne P Dragan; Linda M Sargent; Karlee Babcock; Nina Kinunen; Henry C Pitot
Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Molecular carcinogenesis 2004;40(3):150-9.
2004: Andrea Bilger; L Michelle Bennett; Rey Carabeo; Teresa A Chiaverotti; Cecily Dvorak; Kristin M Liss; Susan A Schadewald; Henry C Pitot; Norman R Drinkwater
A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines.
Genetics 2004;167(2):859-66.
2004: Michael A Thompson; Rendell W Ashton; Henry C Pitot
Mucinous appendiceal adenocarcinoma presenting 5 years after appendectomy.
Annals of internal medicine 2004;140(8):W33.
2004: Charles R Tessier; Glenn A Doyle; Brad A Clark; Henry C Pitot; Jeff Ross
Mammary tumor induction in transgenic mice expressing an RNA-binding protein.
Cancer research 2004;64(1):209-14.
2004: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23-30.
2003: Taro Yamada; Junichi Komoto; Yoshimi Takata; Hirofumi Ogawa; Henry C Pitot; Fusao Takusagawa
Crystal structure of serine dehydratase from rat liver.
Biochemistry 2003;42(44):12854-65.
2003: Matthew P Goetz; Charles Erlichman; Anthony J Windebank; Joel M Reid; Jeff A Sloan; Pamela J Atherton; Alex A. Adjei; Joseph Rubin; Henry C Pitot; Evanthia C Galanis; Matthew M Ames; Richard M Goldberg
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3761-9.
2003: Herbert Manoharan; Karlee Babcock; Jonathan Willi; Henry C Pitot
Biallelic expression of the H19 gene during spontaneous hepatocarcinogenesis in the albumin SV40 T antigen transgenic rat.
Molecular carcinogenesis 2003;38(1):40-7.
2003: Yi-Hua Xu; Henry C Pitot
An improved stereologic method for three-dimensional estimation of particle size distribution from observations in two dimensions and its application.
Computer methods and programs in biomedicine 2003;72(1):1-20.
2003: Tohru Masuda; Hirofumi Ogawa; Takako Matsushima; Seiichi Kawamata; Masakiyo Sasahara; Kazunari Kuroda; Yasuhiro Suzuki; Yoshimi Takata; Mitsuaki Yamazaki; Fusao Takusagawa; Henry C Pitot
Localization and hormonal control of serine dehydratase during metabolic acidosis differ markedly from those of phosphoenolpyruvate carboxykinase in rat kidney.
The international journal of biochemistry & cell biology 2003;35(8):1234-47.
2003: Alex A. Adjei; Gary A Croghan; Charles Erlichman; Randolph S Marks; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Laura M Bruzek; Pamela J Atherton; Alain Thibault; Peter A Palmer; Scott H Kaufmann
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2520-6.
2003: James A Martenson; Antonio P G Vigliotti; Henry C Pitot; Louis H Geeraerts; Daniel J Sargent; Michael G Haddock; Chirantan Ghosh; Michael D Keppen; Tom R Fitch; Richard M Goldberg
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2003;55(5):1305-10.
2003: Steven R Alberts; P M Townley; Richard M Goldberg; S S Cha; Daniel J Sargent; Dennis F Moore; James E Krook; Henry C Pitot; Tom R Fitch; Martin Wiesenfeld; James A Mailliard
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):580-5.
2003: Gregory P Boivin; Kay Washington; Kan Yang; Jerrold M Ward; Theresa P Pretlow; Robert Russell; David G Besselsen; Virginia L Godfrey; Thomas Doetschman; William F Dove; Henry C Pitot; Richard B Halberg; Steven Itzkowitz; Joanna Groden; Robert J Coffey
Pathology of mouse models of intestinal cancer: consensus report and recommendations.
Gastroenterology 2003;124(3):762-77.
2003: Alex A. Adjei; Grace K Dy; Charles Erlichman; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Pamela J Atherton; Tanya Watanabe; Richard S Geary; Jon T Holmlund; F Andrew Dorr
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):115-23.
2002: Cheri E Klein; Elora Gupta; Joel M Reid; Pamela J Atherton; Jeff A Sloan; Henry C Pitot; Mark J Ratain; Helen Kastrissios
Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide.
Clinical pharmacology and therapeutics 2002;72(6):638-47.
2002: Richard M Goldberg; Scott H Kaufmann; Pamela J Atherton; Jeff A Sloan; Alex A. Adjei; Henry C Pitot; Steven R Alberts; Joseph Rubin; L L Miller; Charles Erlichman
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1674-80.
2002: Alex A. Adjei; Joel M Reid; Charles Erlichman; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Stacie Ruben; Scott A Boemer; Pamela J Atherton; Matthew M Ames; Scott H Kaufmann
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
Investigational new drugs 2002;20(3):297-304.
2002: Steven R Alberts; P M Townley; Richard M Goldberg; S S Cha; Dennis F Moore; James E Krook; Henry C Pitot; Tom R Fitch; Martin Wiesenfeld; James A Mailliard; Daniel J Sargent
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):553-7.
2002: Alex A. Adjei; Joel M Reid; Robert B Diasio; Jeff A Sloan; Deborah A Smith; Joseph Rubin; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Pamela J Atherton; Matthew M Ames; Charles Erlichman
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1683-91.
2002: Henry C Pitot; Joel M Reid; Jeff A Sloan; Matthew M Ames; Alex A. Adjei; Joseph Rubin; Pamela G Bagniewski; Pamela J Atherton; Daniel Rayson; Richard M Goldberg; Charles Erlichman
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):712-7.
2002: John J Kresl; Steven E Schild; George T Henning; Leonard L Gunderson; John Donohue; Henry C Pitot; Michael G Haddock; David M Nagorney
Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
International journal of radiation oncology, biology, physics 2002;52(1):167-75.
2001: Rao L Divi; Yvonne P Dragan; Henry C Pitot; Miriam C Poirier
Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen.
Carcinogenesis 2001;22(10):1693-9.
2001: Jeff A Sloan; Pamela J Atherton; J Reid; Henry C Pitot; Charles Erlichman; L Schaaf
Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide.
Cancer chemotherapy and pharmacology 2001;48(3):241-9.
2001: Evanthia C Galanis; Richard M Goldberg; J Reid; Pamela J Atherton; J Sloan; Henry C Pitot; Joseph Rubin; Alex A. Adjei; P Burch; Stephanie L Safgren; T E Witzig; Matthew M Ames; Charles Erlichman
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):701-7.
2001: Steven R Alberts; Charles Erlichman; J Sloan; S H Okuno; Patrick A Burch; Joseph Rubin; Henry C Pitot; Richard M Goldberg; Alex A. Adjei; Pamela J Atherton; S H Kaufmann
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):627-31.
2001: S M Ansell; Henry C Pitot; P A Burch; LK Kvols; Michelle R Mahoney; Joseph Rubin
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors.
Cancer 2001;91(8):1543-8.
2001: Charles Erlichman; Alex A. Adjei; Steven R Alberts; Jeff A Sloan; Richard M Goldberg; Henry C Pitot; Joseph Rubin; Pamela J Atherton; G G Klee; R Humphrey
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):389-95.
2001: Henry C Pitot
Animal models of neoplastic development.
Developments in biologicals 2001;106():53-7; discussion 57-9, 143-60.
2000: Patrick A Burch; Ronald L Richardson; S S Cha; D J Sargent; Henry C Pitot; Judith S Kaur; John K Camoriano
Phase II study of paclitaxel and cisplatin for advanced urothelial cancer.
The Journal of urology 2000;164(5):1538-42.
2000: Henry C Pitot; James A Knost; Michelle R Mahoney; J Kugler; James E Krook; Alan K Hatfield; Daniel J Sargent; Richard M Goldberg
A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma.
Cancer 2000;89(8):1699-705.
2000: Yi-Hua Xu; G L Sattler; H Edwards; Henry C Pitot
Nuclear-labeling index analysis (NLIA), a software package used to perform accurate automation of cell nuclear-labeling index analysis on immunohistochemically stained rat liver samples.
Computer methods and programs in biomedicine 2000;63(1):55-70.
2000: Yvonne P Dragan; Raquel Valdés; M Gomez-Angelats; Antonio Felipe; F Javier Casado; Henry C Pitot; Marçal Pastor-Anglada
Selective loss of nucleoside carrier expression in rat hepatocarcinomas.
Hepatology (Baltimore, Md.) 2000;32(2):239-46.
2000: Henry C Pitot; Richard M Goldberg; Joel M Reid; Jeff A Sloan; P A Skaff; Charles Erlichman; Joseph Rubin; P A Burch; Alex A. Adjei; S A Alberts; L J Schaaf; Gary L Elfring; Langdon L Miller
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2236-44.
2000: Patrick A Burch; J K Breen; Jan C Buckner; Dennis A Gastineau; J A Kaur; Reiner Laus; Douglas J Padley; Madhusudan Peshwa; Henry C Pitot; Ronald L Richardson; B J Smits; P Sopapan; G Strang; Frank H Valone; S Vuk-Pavlović
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2175-82.
2000: JG Teeguarden; Michael A Newton; Yvonne P Dragan; Henry C Pitot
Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 15, 17, and 20.
Molecular carcinogenesis 2000;28(1):51-61.
2000: Henry C Pitot; H Hikita; Yvonne P Dragan; L Sargent; M Haas
Review article: the stages of gastrointestinal carcinogenesis--application of rodent models to human disease.
Alimentary pharmacology & therapeutics 2000;14 Suppl 1():153-60.
2000: Alex A. Adjei; Charles Erlichman; Jeff A Sloan; Joel M Reid; Henry C Pitot; Richard M Goldberg; Prema P Peethambaram; Pamela J Atherton; Lorelei J Hanson; Steven R Alberts; James Jett
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1748-57.
2000: JG Teeguarden; Yvonne P Dragan; Henry C Pitot
Hazard assessment of chemical carcinogens: the impact of hormesis.
Journal of applied toxicology : JAT 2000;20(2):113-20.
2000: MJ Haas; Carol Sattler; Yvonne P Dragan; W L Gast; Henry C Pitot
Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvatecarboxykinase-SV40 T antigen transgenic rats.
Pancreas 2000;20(2):206-14.
2000: Alex A. Adjei; Cheri E Klein; Helen Kastrissios; Richard M Goldberg; Steven R Alberts; Henry C Pitot; Jeff A Sloan; Joel M Reid; Lorelei J Hanson; Pamela J Atherton; Joseph Rubin; Charles Erlichman
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1116-23.
1999: H Hikita; J Vaughan; Karlee Babcock; Henry C Pitot
Short-term fasting and the reversal of the stage of promotion in rat hepatocarcinogenesis: role of cell replication, apoptosis, and gene expression.
Toxicological sciences : an official journal of the Society of Toxicology 1999;52(2 Suppl):17-23.
1999: JG Teeguarden; Yvonne P Dragan; J Singh; J Vaughan; Y H Xu; T Goldsworthy; Henry C Pitot
Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
Toxicological sciences : an official journal of the Society of Toxicology 1999;51(2):211-23.
1999: M Gómez-Angelats; JG Teeguarden; Yvonne P Dragan; Henry C Pitot
Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis.
Molecular carcinogenesis 1999;25(3):157-63.
1999: MJ Haas; Yvonne P Dragan; H Hikita; R Shimel; K Takimoto; S Heath; J Vaughan; Henry C Pitot
Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.
The American journal of pathology 1999;155(1):183-92.
1999: S Song; Henry C Pitot; Paul F Lambert
The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.
Journal of virology 1999;73(7):5887-93.
1999: Edward T. Creagan; Vera J Suman; R J Dalton; Henry C Pitot; Harry J Long; Michael H Veeder; Allen M Vukov; Kendrith M Rowland; James E Krook; John C Michalak
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1884-90.
1999: Yi-Hua Xu; Henry C Pitot
Building quantitative stereology data files with scion image, a public domain image processing and analysis software.
Computer methods and programs in biomedicine 1999;59(2):131-42.
1999: Hirofumi Ogawa; Fusao Takusagawa; Kunihiko Wakaki; H Kishi; M R Eskandarian; Masashi Kobayashi; T Date; Nam-ho Huh; Henry C Pitot
Rat liver serine dehydratase. Bacterial expression and two folding domains as revealed by limited proteolysis.
The Journal of biological chemistry 1999;274(18):12855-60.
1999: Henry C Pitot; EA McElroy; Joel M Reid; A J Windebank; Jeff A Sloan; Charles Erlichman; Pamela G Bagniewski; Denise L Walker; Joseph Rubin; Richard M Goldberg; Alex A. Adjei; Matthew M Ames
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):525-31.
1999: SV Rajkumar; Jan C Buckner; Paula J Schomberg; Henry C Pitot; J N Ingle; Terrence L Cascino
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Neurosurgery 1999;44(1):67-73.
1998: SJ Bulera; Carol Sattler; W L Gast; S Heath; T A Festerling; Henry C Pitot
The mechanism of thioacetamide-induced apoptosis in the L37 albumin-SV40 T-antigen transgenic rat hepatocyte-derived cell line occurs without DNA fragmentation.
In vitro cellular & developmental biology. Animal 1998;34(9):685-93.
1998: K L Steinmetz; I P Pogribny; S Jill James; Henry C Pitot
Hypomethylation of the rat glutathione S-transferase pi (GSTP) promoter region isolated from methyl-deficient livers and GSTP-positive liver neoplasms.
Carcinogenesis 1998;19(8):1487-94.
1998: H Hikita; E F Nuwaysir; J Vaughan; Karlee Babcock; MJ Haas; Yvonne P Dragan; Henry C Pitot
The effect of short-term fasting, phenobarbital and refeeding on apoptotic loss, cell replication and gene expression in rat liver during the promotion stage.
Carcinogenesis 1998;19(8):1417-25.
1998: Henry C Pitot
US pivotal studies of irinotecan in colorectal carcinoma.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):48-53.
1998: Henry C Pitot
Hepatocyte death in hepatocarcinogenesis.
Hepatology (Baltimore, Md.) 1998;28(1):1-5.
1998: Yvonne P Dragan; R J Shimel; N Bahnub; G Sattler; J R Vaughan; V Craig Jordan; Henry C Pitot
Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in rats.
Toxicological sciences : an official journal of the Society of Toxicology 1998;43(2):129-38.
1998: JG Teeguarden; Yvonne P Dragan; Henry C Pitot
Implications of hormesis on the bioassay and hazard assessment of chemical carcinogens.
Human & experimental toxicology 1998;17(5):254-8.
1998: SB Saslow; James S Scolapio; Michael Camilleri; Lee A Forstrom; George M Thomforde; Duane D Burton; Joseph Rubin; Henry C Pitot; Alan R Zinsmeister
Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.
Gut 1998;42(5):628-34.
1998: Yi-Hua Xu; Yvonne P Dragan; H A Campbell; Henry C Pitot
STEREO: a program on a PC-Windows 95 platform for recording and evaluating quantitative stereologic investigations of multistage hepatocarcinogenesis in rodents.
Computer methods and programs in biomedicine 1998;56(1):49-63.
1998: M J Haas; Henry C Pitot
Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
Molecular carcinogenesis 1998;21(2):128-34.
1997: SB Saslow; M D O'Brien; Michael Camilleri; M von der Ohe; Henry A Homburger; G G Klee; Henry C Pitot; Joseph Rubin
Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
The American journal of gastroenterology 1997;92(12):2250-6.
1997: Linda M Sargent; Yvonne P Dragan; G Sattler; Y H Xu; J Wiley; Henry C Pitot
Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms.
Cancer research 1997;57(16):3451-6.
1997: Henry C Pitot; Donald B Wender; Michael J O'Connell; Georgene Schroeder; Richard M Goldberg; Joseph Rubin; James A Mailliard; James A Knost; C Ghosh; RJ Kirschling; Ralph Levitt; Harold E Windschitl
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2910-9.
1997: Joseph Rubin; Evanthia C Galanis; Henry C Pitot; Ronald L Richardson; P A Burch; J William Charboneau; Carl C Reading; Bradley D Lewis; S Stahl; Emmanuel T Akporiaye; David T Harris
Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
Gene therapy 1997;4(5):419-25.
1997: SJ Bulera; MJ Haas; Carol Sattler; Y Li; Henry C Pitot
Cell lines with heterogeneous phenotypes result from a single isolation of albumin-sv40 T-antigen transgenic rat hepatocytes.
Hepatology (Baltimore, Md.) 1997;25(5):1192-203.
1997: James A Martenson; R Swaminathan; Patrick A Burch; R G Santala; Georgene Schroeder; Henry C Pitot; K Wright; John W Kugler; Philip J Stella; G R Garton
Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer.
International journal of radiation oncology, biology, physics 1997;37(3):615-8.
1997: D Rayson; Henry C Pitot; LK Kvols
Regression of metastatic carcinoid tumor after valvular surgery for carcinoid heart disease.
Cancer 1997;79(3):605-11.
1997: H Hikita; J Vaughan; Henry C Pitot
The effect of two periods of short-term fasting during the promotion stage of hepatocarcinogenesis in rats: the role of apoptosis and cell proliferation.
Carcinogenesis 1997;18(1):159-66.
1997: Yvonne P Dragan; H A Campbell; X H Xu; Henry C Pitot
Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats.
Carcinogenesis 1997;18(1):149-58.
1996: Y Q Xie; K Takimoto; Henry C Pitot; W Keith Miskimins; Ronald Lindahl
Characterization of the rat Class 3 aldehyde dehydrogenase gene promoter.
Nucleic acids research 1996;24(21):4185-91.
1996: Yvonne P Dragan; J Singh; Henry C Pitot
Effect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat.
Carcinogenesis 1996;17(9):2043-52.
1996: L Sargent; Yvonne P Dragan; K Babcock; J Wiley; J Klaunig; Henry C Pitot
Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression.
Cancer research 1996;56(13):2992-7.
1996: L Sargent; Yvonne P Dragan; Y H Xu; G Sattler; J Wiley; Henry C Pitot
Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
Cancer research 1996;56(13):2985-91.
1996: SJ Bulera; Carol Sattler; Henry C Pitot
The translational inhibitor cycloheximide represses growth factor depletion-induced apoptosis in an alb-SV40T transgenic rat liver cell line.
Hepatology (Baltimore, Md.) 1996;23(6):1591-601.
1996: L M Sargent; Yvonne P Dragan; Carol Sattler; N Bahnub; G Sattler; P Martin; A Cisneros; J Mann; Snorri S Thorgeirsson; V C Jordan; Henry C Pitot
Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats.
Carcinogenesis 1996;17(5):1051-6.
1996: Yvonne P Dragan; S Fahey; E Nuwaysir; Carol Sattler; K Babcock; J Vaughan; R McCague; V C Jordan; Henry C Pitot
The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis.
Carcinogenesis 1996;17(3):585-94.
1996: R Herber; A Liem; Henry C Pitot; Paul F Lambert
Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
Journal of virology 1996;70(3):1873-81.
1996: Henry C Pitot; Yvonne P Dragan; JG Teeguarden; S Hsia; H Campbell
Quantitation of multistage carcinogenesis in rat liver.
Toxicologic pathology 1996;24(1):119-28.
1996: Henry C Pitot
Stage-specific gene expression during hepatocarcinogenesis in the rat.
Journal of cancer research and clinical oncology 1996;122(5):257-65.
1995: Henry C Pitot
The role of receptors in multistage carcinogenesis.
Mutation research 1995;333(1-2):3-14.
1995: V P Dragan; J Vaughan; V C Jordan; Henry C Pitot
Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats.
Carcinogenesis 1995;16(11):2733-41.
1995: T Deguchi; Henry C Pitot
Expression of c-myc in altered hepatic foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phenobarbital.
Molecular carcinogenesis 1995;14(3):152-9.
1995: Yvonne P Dragan; J Hully; K Baker; R Crow; M J Mass; Henry C Pitot
Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
Toxicology 1995;102(1-2):161-75.
1995: M J Neveu; J R Hully; K L Babcock; J Vaughan; E L Hertzberg; Bruce Nicholson; D L Paul; Henry C Pitot
Proliferation-associated differences in the spatial and temporal expression of gap junction genes in rat liver.
Hepatology (Baltimore, Md.) 1995;22(1):202-12.
1995: Yvonne P Dragan; JG Teeguarden; H Campbell; S Hsia; Henry C Pitot
The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
Cancer letters 1995;93(1):73-83.
1995: E F Nuwaysir; Yvonne P Dragan; Colin R Jefcoate; V C Jordan; Henry C Pitot
Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver.
Cancer research 1995;55(8):1780-6.
1995: Henry C Pitot
The tamoxifen controversy--clinical chemopreventive agent and experimental carcinogen.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1995;208(2):139-40.
1995: Henry C Pitot; Yvonne P Dragan
The instability of tumor promotion in relation to human cancer risk.
Progress in clinical and biological research 1995;391():21-38.
1995: J Feimer; Y Xie; K Takimoto; D Asman; Henry C Pitot; Ronald Lindahl
Class 3 aldehyde dehydrogenase. A northern perspective in the land down under.
Advances in experimental medicine and biology 1995;372():137-41.
1994: Yvonne P Dragan; H A Campbell; K Baker; J Vaughan; M Mass; Henry C Pitot
Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats.
Carcinogenesis 1994;15(11):2587-91.
1994: M J Neveu; Carol Sattler; G L Sattler; J R Hully; E L Hertzberg; D L Paul; Bruce Nicholson; Henry C Pitot
Differences in the expression of connexin genes in rat hepatomas in vivo and in vitro.
Molecular carcinogenesis 1994;11(3):145-54.
1994: Yvonne P Dragan; J Hully; R Crow; M Mass; Henry C Pitot
Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
Carcinogenesis 1994;15(9):1939-47.
1994: J R Hully; Y Su; J K Lohse; Anne E Griep; Carol Sattler; MJ Haas; Yvonne P Dragan; J Peterson; M Neveu; Henry C Pitot
Transgenic hepatocarcinogenesis in the rat.
The American journal of pathology 1994;145(2):384-97.
1994: K Takimoto; Ronald Lindahl; T J Dunn; Henry C Pitot
Structure of the 5' flanking region of class 3 aldehyde dehydrogenase in the rat.
Archives of biochemistry and biophysics 1994;312(2):539-46.
1994: Yvonne P Dragan; J R Hully; Jun Nakamura; M J Mass; James A Swenberg; Henry C Pitot
Biochemical events during initiation of rat hepatocarcinogenesis.
Carcinogenesis 1994;15(7):1451-8.
1994: L M Sargent; Yvonne P Dragan; N Bahnub; J E Wiley; Carol Sattler; P Schroeder; G L Sattler; V C Jordan; Henry C Pitot
Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats.
Cancer research 1994;54(13):3357-60.
1994: M J Neveu; K L Babcock; E L Hertzberg; D L Paul; Bruce Nicholson; Henry C Pitot
Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
Cancer research 1994;54(12):3145-52.
1994: M J Neveu; J R Hully; K L Babcock; E L Hertzberg; Bruce Nicholson; D L Paul; Henry C Pitot
Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver.
Journal of cell science 1994;107 ( Pt 1)():83-95.
1994: Henry C Pitot; Yvonne P Dragan
The multistage nature of chemically induced hepatocarcinogenesis in the rat.
Drug metabolism reviews 1994;26(1-2):209-20.
1994: Yvonne P Dragan; S Fahey; K Street; J Vaughan; V C Jordan; Henry C Pitot
Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.
Breast cancer research and treatment 1994;31(1):11-25.
1993: T Borges; R E Peterson; Henry C Pitot; Larry W Robertson; Howard P Glauert
Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of two-stage hepatocarcinogenesis in rats.
Cancer letters 1993;72(1-2):111-20.
1993: Henry C Pitot
The molecular biology of carcinogenesis.
Cancer 1993;72(3 Suppl):962-70.
1993: Yvonne P Dragan; J Peterson; Henry C Pitot
Comparison of hepatocyte phenotypes at the glutathione transferase and albumin loci in Sprague-Dawley and Nagase analbuminemic rats and F1 progeny after initiation and promotion.
Carcinogenesis 1993;14(7):1313-9.
1993: A I Musat; Carol Sattler; G L Sattler; Henry C Pitot
Reestablishment of cell polarity of rat hepatocytes in primary culture.
Hepatology (Baltimore, Md.) 1993;18(1):198-205.
1993: Y Li; G L Sattler; Henry C Pitot
Oxaloacetate induces DNA synthesis and mitosis in primary cultured rat hepatocytes in the absence of EGF.
Biochemical and biophysical research communications 1993;193(3):1339-46.
1993: D C Asman; K Takimoto; Henry C Pitot; T J Dunn; Ronald Lindahl
Organization and characterization of the rat class 3 aldehyde dehydrogenase gene.
The Journal of biological chemistry 1993;268(17):12530-6.
1993: Paul F Lambert; H Pan; Henry C Pitot; A Liem; M Jackson; Anne E Griep
Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(12):5583-7.
1993: Yvonne P Dragan; Y H Xu; Henry C Pitot
The effect of the dose of diethylnitrosamine on the initiation of altered hepatic foci in neonatal female rats.
Carcinogenesis 1993;14(3):385-91.
1993: Yvonne P Dragan; C Laufer; A J Koleske; Norman R Drinkwater; Henry C Pitot
Quantitative comparison of initiation and mutation phenotypes in hepatocytes of the analbuminemic rat.
Japanese journal of cancer research : Gann 1993;84(2):175-83.
1993: D C Asman; K Takimoto; Henry C Pitot; Ronald Lindahl
Preliminary characterization of the rat class 3 aldehyde dehydrogenase gene.
Advances in experimental medicine and biology 1993;328():81-6.
1993: Henry C Pitot; Y P Dragan
Stage of tumor progression, progressor agents, and human risk.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1993;202(1):37-43.
1993: Yvonne P Dragan; L Sargent; Y D Xu; Y H Xu; Henry C Pitot
The initiation-promotion-progression model of rat hepatocarcinogenesis.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1993;202(1):16-24.
1992: Y Su; Henry C Pitot
Identification of regions in the rat serine dehydratase gene responsible for regulation by cyclic AMP alone and in the presence of glucocorticoids.
Molecular and cellular endocrinology 1992;90(1):141-6.
1992: K Takimoto; R Lindahl; Henry C Pitot
Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of aldehyde dehydrogenase in hepatoma cells.
Archives of biochemistry and biophysics 1992;298(2):493-7.
1992: Lorraine F Meisner; B Roloff; L Sargent; Henry C Pitot
Interactive cytogenetic effects on rat bone-marrow due to chronic ingestion of 2,5,2',5' and 3,4,3',4' PCBs.
Mutation research 1992;283(3):179-83.
1992: Y Su; R Kanamoto; H Ogawa; Henry C Pitot
Regulatory elements for the tissue-specific expression of the rat serine dehydratase-encoding gene.
Gene 1992;120(2):301-6.
1992: Suzanne Hendrich; A O Leveston; Henry C Pitot
Ovariectomy promotes the growth of altered hepatic foci after withdrawal and reintroduction of phenobarbital during hepatocarcinogenesis in rats.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1992;1(6):407-14.
1992: Curtis C Harris; S Hirohashi; N Ito; Henry C Pitot; T Sugimura; M Terada; J Yokota
Multistage carcinogenesis: the Twenty-Second International Symposium of the Princess Takamatsu Cancer Research Fund.
Cancer research 1992;52(17):4837-40.
1992: Y Su; Henry C Pitot
Location and characterization of multiple glucocorticoid-responsive elements in the rat serine dehydratase gene.
Archives of biochemistry and biophysics 1992;297(2):239-43.
1992: Yvonne P Dragan; X H Xu; T L Goldsworthy; H A Campbell; R R Maronpot; Henry C Pitot
Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
Carcinogenesis 1992;13(8):1389-95.
1992: Henry C Pitot
Analbuminemic rats.
Japanese journal of cancer research : Gann 1992;83(7):inside front cover.
1992: Yvonne P Dragan; Henry C Pitot
The role of the stages of initiation and promotion in phenotypic diversity during hepatocarcinogenesis in the rat.
Carcinogenesis 1992;13(5):739-50.
1992: L M Sargent; G L Sattler; B Roloff; Y H Xu; Carol Sattler; Lorraine F Meisner; Henry C Pitot
Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2',5'-tetrachlorobiphenyl, and/or 3,4,3'4'-tetrachlorobiphenyl in rat liver.
Cancer research 1992;52(4):955-62.
1992: Yvonne P Dragan; Henry C Pitot
Multistage hepatocarcinogenesis in the rat: insights into risk estimation.
Progress in clinical and biological research 1992;374():261-79.
1991: Henry C Pitot
Endogenous carcinogenesis: the role of tumor promotion.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1991;198(2):661-6.
1991: R Kanamoto; Y Su; Henry C Pitot
Hormonal regulation of serine dehydratase gene expression in liver and kidney of the adrenalectomized rat.
Molecular endocrinology (Baltimore, Md.) 1991;5(11):1661-8.
1991: K Takimoto; R Lindahl; Henry C Pitot
Superinduction of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of aldehyde dehydrogenase by the inhibition of protein synthesis.
Biochemical and biophysical research communications 1991;180(2):953-9.
1991: R Kanamoto; Y Su; Henry C Pitot
Effects of glucose, insulin, and cAMP on transcription of the serine dehydratase gene in rat liver.
Archives of biochemistry and biophysics 1991;288(2):562-6.
1991: Toshihiro Mitaka; G L Sattler; Henry C Pitot
The bicarbonate ion is essential for efficient DNA synthesis by primary cultured rat hepatocytes.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1991;27A(7):549-56.
1991: Y D Xu; Yvonne P Dragan; T Young; Henry C Pitot
The effect of the format of administration and the total dose of phenobarbital on altered hepatic foci following initiation in female rats with diethylnitrosamine.
Carcinogenesis 1991;12(6):1009-16.
1991: Henry C Pitot; Yvonne P Dragan; L Sargent; Y H Xu
Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
Environmental health perspectives 1991;93():181-9.
1991: Howard P Glauert; L T Lay; W S Kennan; Henry C Pitot
Effect of dietary fat on the initiation of hepatocarcinogenesis by diethylnitrosamine or 2-acetylaminofluorene in rats.
Carcinogenesis 1991;12(6):991-5.
1991: Toshihiro Mitaka; G L Sattler; Henry C Pitot
Amino acid-rich medium (Leibovitz L-15) enhances and prolongs proliferation of primary cultured rat hepatocytes in the absence of serum.
Journal of cellular physiology 1991;147(3):495-504.
1991: L Sargent; Yvonne P Dragan; C Erickson; C J Laufer; Henry C Pitot
Study of the separate and combined effects of the non-planar 2,5,2',5'- and the planar 3,4,3',4'-tetrachlorobiphenyl in liver and lymphocytes in vivo.
Carcinogenesis 1991;12(5):793-800.
1991: Yvonne P Dragan; T Rizvi; Y H Xu; J R Hully; N Bawa; H A Campbell; R R Maronpot; Henry C Pitot
An initiation-promotion assay in rat liver as a potential complement to the 2-year carcinogenesis bioassay.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1991;16(3):525-47.
1991: J E Sheehan; Henry C Pitot; Charles B Kasper
Transcriptional regulation and localization of the tissue-specific induction of epoxide hydrolase by lead acetate in rat kidney.
The Journal of biological chemistry 1991;266(8):5122-7.
1991: Henry C Pitot; Yvonne P Dragan; M J Neveu; T A Rizvi; J R Hully; H A Campbell
Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
Progress in clinical and biological research 1991;369():517-32.
1991: Henry C Pitot; Yvonne P Dragan; Y H Xu; J Peterson; J Hully; H Campbell
Nakahara Memorial Lecture. Pathways of carcinogenesis--genetic and epigenetic.
Princess Takamatsu symposia 1991;22():21-33.
1991: Toshihiro Mitaka; Carol Sattler; G L Sattler; L M Sargent; Henry C Pitot
Multiple cell cycles occur in rat hepatocytes cultured in the presence of nicotinamide and epidermal growth factor.
Hepatology (Baltimore, Md.) 1991;13(1):21-30.
1991: Henry C Pitot
Characterization of the stage of progression in hepatocarcinogenesis in the rat.
Basic life sciences 1991;57():3-18.
1991: Yvonne P Dragan; Y D Xu; Henry C Pitot
Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis.
Preventive medicine 1991;20(1):15-26.
1991: J S Zhang; Y H Xu; G L Sattler; Henry C Pitot
DNA damage and repair in gamma-glutamyltranspeptidase-positive and negative hepatocytes in primary culture from carcinogen-treated rats.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1991;196(1):47-53.
1990: Y Su; R Kanamoto; D A Miller; H Ogawa; Henry C Pitot
Regulation of the expression of the serine dehydratase gene in the kidney and liver of the rat.
Biochemical and biophysical research communications 1990;170(2):892-9.
1990: Y H Xu; H A Campbell; G L Sattler; S Hendrich; R Maronpot; K Sato; Henry C Pitot
Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Cancer research 1990;50(3):472-9.
1990: AR Moser; Henry C Pitot; William F Dove
A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.
Science (New York, N.Y.) 1990;247(4940):322-4.
1990: Henry C Pitot; Yvonne P Dragan; Y H Xu; M Pyron; C Laufer; T Rizvi
Role of altered hepatic foci in the stages of carcinogenesis.
Progress in clinical and biological research 1990;340D():81-95.
1990: Henry C Pitot
Altered hepatic foci: their role in murine hepatocarcinogenesis.
Annual review of pharmacology and toxicology 1990;30():465-500.
1990: Henry C Pitot
Proto-oncogene activation in multistage murine hepatocarcinogenesis.
Progress in clinical and biological research 1990;331():311-24.
1990: M J Neveu; J R Hully; D L Paul; Henry C Pitot
Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.
Cancer communications 1990;2(1):21-31.
1989: T J Dunn; A J Koleske; Ronald Lindahl; Henry C Pitot
Phenobarbital-inducible aldehyde dehydrogenase in the rat. cDNA sequence and regulation of the mRNA by phenobarbital in responsive rats.
The Journal of biological chemistry 1989;264(22):13057-65.
1989: Howard P Glauert; Henry C Pitot
Effect of the antihistamine, methapyrilene, as an initiator of hepatocarcinogenesis in female rats.
Cancer letters 1989;46(3):189-94.
1989: N A Turner; Henry C Pitot
Dependence of the induction of cytochrome P-450 by phenobarbital in primary cultures of adult rat hepatocytes on the composition of the culture medium.
Biochemical pharmacology 1989;38(14):2247-51.
1989: Henry C Pitot
Progression: the terminal stage in carcinogenesis.
Japanese journal of cancer research : Gann 1989;80(7):599-607.
1989: D C Goodspeed; T J Dunn; C D Miller; Henry C Pitot
Human gamma-glutamyl transpeptidase cDNA: comparison of hepatoma and kidney mRNA in the human and rat.
Gene 1989;76(1):1-9.
1989: L Sargent; Y H Xu; G L Sattler; Lorraine F Meisner; Henry C Pitot
Ploidy and karyotype of hepatocytes isolated from enzyme-altered foci in two different protocols of multistage hepatocarcinogenesis in the rat.
Carcinogenesis 1989;10(2):387-91.
1989: Suzanne Hendrich; H P Glauert; Henry C Pitot
A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the rat.
Nutrition and cancer 1989;12(3):249-58.
1989: Henry C Pitot; H A Campbell; R Maronpot; N Bawa; T A Rizvi; Y H Xu; L Sargent; Yvonne P Dragan; M Pyron
Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat.
Toxicologic pathology 1989;17(4 Pt 1):594-611; discussion 611-2.
1989: David G Beer; Henry C Pitot
Proto-oncogene activation during chemically induced hepatocarcinogenesis in rodents.
Mutation research 1989;220(1):1-10.
1989: Henry C Pitot; D Goodspeed; T Dunn; S Hendrich; R R Maronpot; S Moran
Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis.
Toxicology and applied pharmacology 1989;97(1):23-34.
1988: Carol Sattler; N Sawada; G L Sattler; Henry C Pitot
Electron microscopic and time lapse studies of mitosis in cultured rat hepatocytes.
Hepatology (Baltimore, Md.) 1988;8(6):1540-9.
1988: Henry C Pitot; K Sato
U.S.-Japan Cooperative Cancer Research Program Conference. Glutathione S-transferase and carcinogenesis.
Cancer research 1988;48(21):6249-51.
1988: Y H Xu; G L Sattler; Henry C Pitot
A method for the comparative study of replicative DNA synthesis in GGT-positive and GGT-negative hepatocytes in primary culture isolated from carcinogen-treated rats.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1988;24(10):995-1000.
1988: T J Dunn; Ronald Lindahl; Henry C Pitot
Differential gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Noncoordinate regulation of a TCDD-induced aldehyde dehydrogenase and cytochrome P-450c in the rat.
The Journal of biological chemistry 1988;263(22):10878-86.
1988: H Ogawa; D A Miller; T Dunn; Y Su; J M Burcham; C Peraino; M Fujioka; K Babcock; Henry C Pitot
Isolation and nucleotide sequence of the cDNA for rat liver serine dehydratase mRNA and structures of the 5' and 3' flanking regions of the serine dehydratase gene.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(16):5809-13.
1988: N A Turner; N M Wilson; C R Jefcoate; Henry C Pitot
The expression and metabolic activity of cytochrome P-450 isozymes in control and phenobarbital-induced primary cultures of rat hepatocytes.
Archives of biochemistry and biophysics 1988;263(1):204-15.
1988: David G Beer; M J Neveu; D L Paul; U R Rapp; Henry C Pitot
Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms.
Cancer research 1988;48(6):1610-7.
1988: T A Rizvi; W Kennan; Y H Xu; Henry C Pitot
The effects of dose and duration of administration on the promotion index of phenobarbital in multistage hepatocarcinogenesis in the rat.
APMIS. Supplementum 1988;2():262-74.
1988: Suzanne Hendrich; H P Glauert; Henry C Pitot
Dietary effects on initiation and promotion of hepatocarcinogenesis in rat.
Journal of cancer research and clinical oncology 1988;114(2):149-57.
1987: Henry C Pitot; H A Campbell
An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.
Environmental health perspectives 1987;76():49-56.
1987: M J Merrill; Henry C Pitot
Inhibition of cyclic AMP-dependent induction of ornithine aminotransferase by simple carbohydrates in cultured hepatocytes.
Archives of biochemistry and biophysics 1987;259(2):250-61.
1987: N Sawada; J L Staecker; Henry C Pitot
Effects of tumor-promoting agents 12-O-tetradecanoylphorbol-13-acetate and phenobarbital on DNA synthesis of rat hepatocytes in primary culture.
Cancer research 1987;47(21):5665-71.
1987: Henry C Pitot; T L Goldsworthy; S Moran; W Kennan; H P Glauert; R R Maronpot; H A Campbell
A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
Carcinogenesis 1987;8(10):1491-9.
1987: S Hendrich; H A Campbell; Henry C Pitot
Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat.
Carcinogenesis 1987;8(9):1245-50.
1986: Suzanne Hendrich; H P Glauert; Henry C Pitot
The phenotypic stability of altered hepatic foci: effects of withdrawal and subsequent readministration of phenobarbital.
Carcinogenesis 1986;7(12):2041-5.
1986: Henry C Pitot
The molecular determinants of carcinogenesis.
Symposium on Fundamental Cancer Research 1986;39():187-96.
1984: Howard P Glauert; J K Reddy; W S Kennan; G L Sattler; V S Rao; Henry C Pitot
Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella.
Cancer letters 1984;24(2):147-56.
1984: T Goldsworthy; H A Campbell; Henry C Pitot
The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration.
Carcinogenesis 1984;5(1):67-71.
1982: Henry C Pitot; T Goldsworthy; S Moran; A E Sirica; J Weeks
Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
Carcinogenesis; a comprehensive survey 1982;7():85-98.
1981: Henry C Pitot; T Goldsworthy; S Moran
The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.
Journal of supramolecular structure and cellular biochemistry 1981;17(2):133-46.
1980: Henry C Pitot; T Goldsworthy; H A Campbell; A Poland
Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
Cancer research 1980;40(10):3616-20.